Bronchiolitis therapies and misadventures.
Bronchiolitis
Outcomes
Treatment
Journal
Paediatric respiratory reviews
ISSN: 1526-0550
Titre abrégé: Paediatr Respir Rev
Pays: England
ID NLM: 100898941
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
21
09
2022
accepted:
26
09
2022
medline:
26
6
2023
pubmed:
25
10
2022
entrez:
24
10
2022
Statut:
ppublish
Résumé
Viral bronchiolitis, which is most commonly caused by an infection with the respiratory syncytial virus (RSV), can lead to respiratory difficulties in young children which may require hospitalization. Despite years of research and medical trials, the mainstay of bronchiolitis treatment remains supportive only. This review provides an overview of the history of different treatments for bronchiolitis, including those that failed, as well as new therapies that are under study. Future studies for the treatment of bronchiolitis should consider different age-groups, important subgroups (i.e., those with a prior history of wheezing, those with a family history of asthma and those with non-RSV viral etiologies) whose response to treatment may differ from that of the composite group.
Identifiants
pubmed: 36280580
pii: S1526-0542(22)00066-5
doi: 10.1016/j.prrv.2022.09.003
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
49-56Informations de copyright
Copyright © 2022. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: MSS: Participates on the speaker’s bureau for Sanofi Pasteur. BKR, RSNL: No conflicts of interest related to this manuscript to declare.